Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
Astec LifeSciences Dividend Announcement
• Astec LifeSciences announced a annually dividend of ₹1.50 per ordinary share which will be made payable on 2023-08-01. Ex dividend date: 2023-07-21
• Astec LifeSciences annual dividend for 2023 was ₹1.50
• Astec LifeSciences's trailing twelve-month (TTM) dividend yield is -%
Astec LifeSciences Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-07-21 | ₹1.50 | annually | 2023-08-01 |
2022-07-19 | ₹1.50 | annually | 2022-07-29 |
2021-07-22 | ₹1.50 | annually | 2021-08-27 |
2020-07-16 | ₹1.50 | annually | 2020-07-31 |
2019-07-18 | ₹1.50 | annually | 2019-08-05 |
2018-07-19 | ₹1.50 | annually | 2018-08-10 |
2017-07-17 | ₹1.50 | annually | 2017-08-07 |
2015-09-15 | ₹1.25 | annually | 2015-10-22 |
2014-09-15 | ₹1.00 | annually | 2014-10-23 |
2013-09-02 | ₹0.75 | annually | 2013-10-17 |
2012-09-13 | ₹0.50 | annually | 2012-10-25 |
2011-09-15 | ₹0.50 | annually | 2011-10-23 |
Astec LifeSciences Dividend per year
Astec LifeSciences Dividend growth
Astec LifeSciences Dividend Yield
Astec LifeSciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Astec LifeSciences stock? Use our calculator to estimate your expected dividend yield:
Astec LifeSciences Financial Ratios
Astec LifeSciences Dividend FAQ
Other factors to consider when evaluating Astec LifeSciences as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Astec LifeSciences stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Astec LifeSciences's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Astec LifeSciences publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Astec LifeSciences distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Astec LifeSciences are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Astec LifeSciences sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Astec LifeSciences distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Astec LifeSciences declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Astec LifeSciences's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Astec LifeSciences's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.